Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BIO CIRCLE SURFACE TECHNOLOGY ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.3% 2.3%   Bankruptcy risk   7.3% 8.0% 1.8% 1.0% 1.0% 0.9% 12.5% 12.3%   Credit score (0-100)   35 32 71 84 87 86 19 19   Credit rating   BBB BB A A A A BB BB   Credit limit (kDKK)   0.0 0.0 3.2 258.8 385.0 427.5 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,569 5,058 6,832 6,398 7,781 8,834 0.0 0.0   EBITDA   444 272 2,200 1,226 1,840 1,572 0.0 0.0   EBIT   373 229 2,116 1,154 1,735 1,368 0.0 0.0   Pre-tax profit (PTP)   303.9 179.3 2,073.5 1,124.0 1,700.2 1,323.1 0.0 0.0   Net earnings   229.6 134.9 1,626.4 869.6 1,318.8 1,023.5 0.0 0.0   Pre-tax profit without non-rec. items   304 179 2,073 1,124 1,700 1,323 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   61.8 168 241 140 201 460 0.0 0.0   Shareholders equity total   521 656 2,283 2,702 3,271 3,045 2,965 2,965   Interest-bearing liabilities   563 583 449 2,512 2,898 3,148 0.0 0.0   Balance sheet total (assets)   4,963 5,495 7,162 6,765 8,047 8,475 2,965 2,965   Net Debt   115 40.2 -807 1,304 1,749 1,346 -2,965 -2,965     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,569 5,058 6,832 6,398 7,781 8,834 0.0 0.0   Gross profit growth   17.0% 10.7% 35.1% -6.4% 21.6% 13.5% -100.0% 0.0%   Employees   7 8 6 9 11 13 0 0   Employee growth %   16.7% 14.3% -25.0% 50.0% 22.2% 18.2% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,963 5,495 7,162 6,765 8,047 8,475 2,965 2,965   Balance sheet change%   -2.3% 10.7% 30.3% -5.5% 19.0% 5.3% -65.0% 0.0%   Added value   444.3 271.6 2,199.7 1,225.9 1,806.8 1,571.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -57 63 -10 -173 -44 56 -460 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   8.2% 4.5% 31.0% 18.0% 22.3% 15.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   7.7% 4.5% 33.5% 16.9% 23.4% 16.7% 0.0% 0.0%   ROI %   39.1% 18.9% 94.8% 27.3% 29.0% 21.4% 0.0% 0.0%   ROE %   56.5% 22.9% 110.7% 34.9% 44.2% 32.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   10.5% 11.9% 31.9% 39.9% 40.7% 35.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   25.8% 14.8% -36.7% 106.3% 95.1% 85.6% 0.0% 0.0%   Gearing %   108.0% 88.8% 19.7% 93.0% 88.6% 103.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   14.6% 10.2% 9.2% 3.5% 1.3% 1.9% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.6 0.7 1.1 1.2 1.2 1.1 0.0 0.0   Current Ratio   1.1 1.1 1.5 1.8 1.7 1.5 0.0 0.0   Cash and cash equivalent   448.5 542.4 1,256.1 1,208.8 1,149.3 1,801.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   503.7 588.4 2,358.2 2,828.4 3,221.7 2,769.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   63 34 367 136 164 121 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   63 34 367 136 167 121 0 0   EBIT / employee   53 29 353 128 158 105 0 0   Net earnings / employee   33 17 271 97 120 79 0 0